Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor

Neuropharmacology

Volumn 39, Issue 3, 2000, Pages 382-390

  Clifford, Jeremiah J ^a   Usiello, Alessandro ^b   Vallone, Daniela ^b   Kinsella, Anthony ^c   Borrelli, Emiliana ^b   Waddington, John L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Behavioural phenotype; D2 like receptors; Dopamine D2 receptor; RU 24213; Targeted gene deletion; Topographical assessment

Indexed keywords

DOPAMINE 2 RECEPTOR; N (3 HYDROXYPHENETHYL) N (PHENETHYL)PROPYLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; GENE DELETION; GROOMING; LOCOMOTION; MALE; MASTICATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REARING; SNIFFING; STEREOTYPY; TRANSGENIC MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE AGONISTS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; PHENETHYLAMINES; PHENOTYPE; RECEPTORS, DOPAMINE D2;

EID: 0033969336     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00150-1     Document Type: Article

References (21)

1. 2 receptors. Nature. 377:1995;424-428.
2. 2 dopamine receptor cDNA. Nature. 336:1988;783-787.
3. Claudi F., Cardellini M., Di Stefano A., Giorgioni G., Cantalamessa F., Reno F., Balduini W. Activity of N-(2-phenylethyl)-N-n-propyl-2-(3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands. Drug Design and Discovery. 11:1994;115-125.
4. 3 dopamine receptor antagonists using an ethologically-based approach. Psychopharmacology. 136:1998;284-290.
5. 1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology. 37:1998;1595-1602.
6. 2 dopamine receptor. British Journal of Pharmacology 126 (supplement), 62P.
7. Colgan P.W. Quantitative Ethology. 1978;Wiley, New York.
8. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., Hitzemann R.J., Maxson S.C., Miner L.L., Silva A.J., Wehner J.M., Wynshaw-Boris A., Paylor R. Behavioural phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology. 132:1997;107-124.
9. 1A dopamine receptors. Proceedings of the National Academy of Sciences of the USA. 91:1994;12564-12568.
10. Euvrard C., Ferland L., Dipaolo T., Beaulieu M., Labrie F., Oberlander C., Raynaud J.P., Boissier J.R. Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels. Neuropharmacology. 19:1980;379-386.
11. 2 receptor isoforms. Nature. 342:1989;923-925.
12. Jaber M., Robinson S.W., Missale C., Caron M.G. Dopamine receptors and brain function. Neuropharmacology. 35:1996;1503-1519.
13. 2 receptor-deficient mice. Neuron. 19:1997;103-113.
14. 2 dopamine receptor-deficient mice is determined by gene dosage, genetic background and developmental adaptions. Journal of Neuroscience. 18:1998;3470-3479.
15. Mashurano M., Waddington J.L. Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK and F 38393. Neuropharmacology. 25:1986;947-949.
16. 3) as a target for neuroleptics. Nature. 347:1990;146-151.
17. Starr B.S., Starr M.S. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors. Neuropharmacology. 25:1986;455-463.
18. 4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
19. 2-like dopamine receptor systems. Niznik H.B. Dopamine Receptors and Transporters. 1994;513-538 Marcel Dekker, New York.
20. 2-like" receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 19:1995;811-831.
21. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioural responses. Cell. 79:1994;729-742.